ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
Dow Jones
38.675,68
1,18%
Euro vs US Dollar
1,07725
-0,01%
Bitcoin
63.094,65
0,33%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Sonoma Pharmaceuticals Inc (SNOA)

  7. Sonoma Pharmaceuticals Inc (SNOA) News

SNOA

Sonoma Pharmaceuticals (SNOA)

Sonoma Pharmaceuticals Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:SNOA
DatumZeitQuelleÜberschriftSymbolFirma
08/03/202422h29Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SNOASonoma Pharmaceuticals Inc
08/03/202422h27Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SNOASonoma Pharmaceuticals Inc
08/02/202422h01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SNOASonoma Pharmaceuticals Inc
10/01/202413h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SNOASonoma Pharmaceuticals Inc
09/01/202422h47Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SNOASonoma Pharmaceuticals Inc
29/12/202323h26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SNOASonoma Pharmaceuticals Inc
29/12/202323h25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SNOASonoma Pharmaceuticals Inc
29/12/202323h25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SNOASonoma Pharmaceuticals Inc
29/12/202323h24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SNOASonoma Pharmaceuticals Inc
29/12/202323h23Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SNOASonoma Pharmaceuticals Inc
15/12/202323h30Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SNOASonoma Pharmaceuticals Inc
21/11/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SNOASonoma Pharmaceuticals Inc
13/11/202322h01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SNOASonoma Pharmaceuticals Inc
03/11/202321h30Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:SNOASonoma Pharmaceuticals Inc
30/10/202312h30Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:SNOASonoma Pharmaceuticals Inc
27/10/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SNOASonoma Pharmaceuticals Inc
13/10/202323h19Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:SNOASonoma Pharmaceuticals Inc
11/10/202322h30Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:SNOASonoma Pharmaceuticals Inc
11/10/202313h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SNOASonoma Pharmaceuticals Inc
28/09/202322h41Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SNOASonoma Pharmaceuticals Inc
21/09/202315h35GlobeNewswire Inc.Dawson James Securities Announces October Date for 8th Annual Small Cap Growth ConferenceNASDAQ:SNOASonoma Pharmaceuticals Inc
19/09/202322h30Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:SNOASonoma Pharmaceuticals Inc
10/08/202322h01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SNOASonoma Pharmaceuticals Inc
27/07/202322h30Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:SNOASonoma Pharmaceuticals Inc
21/07/202323h00Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:SNOASonoma Pharmaceuticals Inc
14/07/202323h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SNOASonoma Pharmaceuticals Inc
03/07/202323h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SNOASonoma Pharmaceuticals Inc
03/07/202323h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SNOASonoma Pharmaceuticals Inc
21/06/202322h17Edgar (US Regulatory)Annual Report (10-k)NASDAQ:SNOASonoma Pharmaceuticals Inc
10/05/202313h31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNOASonoma Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:SNOA

Kürzlich von Ihnen besucht

NASDAQ
MSFT
Microsoft
NASDAQ
NVDA
NVIDIA
TG
CBK
Commerzbank
CCOM
US30
US 30
USOTC
RHHBY
Roche (QX)
TG
432
Arbor Metals
NASDAQ
AMZN
Amazon.com
TG
DTE
Deutsche Telekom
TG
BAYN
Bayer
USOTC
DTEGY
Deutsche Telekom (QX)
TG
RHM
Rheinmetall
DBI
TDXP
Tec DAX
NYSE
MRK
Merck
COIN
SOLUSD
Solana
USOTC
BASFY
BASF (QX)
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten